Pharming (PHAR) Assets (2019 - 2026)
Pharming (PHAR) reported Assets of $468 million for Q2 2026, up 4.9% from $446.3 million a year earlier but down 4.4% from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Pharming posted Assets of $500 million, up 25.0% from FY2024.
- Assets has a five-year compound annual growth rate of 3.6% (FY2020 to FY2025).
- By year, Assets came in at $399.99 million in FY2024 (-13.6%), $462.85 million in FY2023 (+8.7%), $425.8 million in FY2022 (+7.2%) and $397.32 million in FY2021 (-5.1%).
- Five-year quarterly Assets spans a low of $382,323 in Q3 2022 and a high of $500 million in Q4 2025.
- Year over year, Assets has now increased in each of the last five quarters, with growth averaging 5.6% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q4 2025 (growth of 25.0%); the low point was Q3 2022 (a decline of 99.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $489.4 million (Q1 2026), $500 million (Q4 2025) and $473.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Pharming | 702.38 Mn | -127.78 Mn | 141.47 Mn | 468.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 468.00 Mn |
| Mar 31, 2026 | 489.40 Mn |
| Dec 31, 2025 | 500.00 Mn |
| Sep 30, 2025 | 473.79 Mn |
| Jun 30, 2025 | 446.30 Mn |
| Mar 31, 2025 | 403.20 Mn |
| Dec 31, 2024 | 399.99 Mn |
| Sep 30, 2024 | 425.51 Mn |
| Jun 30, 2024 | 415.93 Mn |
| Mar 31, 2024 | 441.67 Mn |
| Dec 31, 2023 | 462.85 Mn |
| Sep 30, 2023 | 436.47 Mn |
| Jun 30, 2023 | 429.81 Mn |
| Mar 31, 2023 | 423.00 Mn |
| Dec 31, 2022 | 425.80 Mn |
| Sep 30, 2022 | 382,323.00 |
| Jun 30, 2022 | 393.90 Mn |
| Mar 31, 2022 | 392.80 Mn |
| Dec 31, 2021 | 401,021.30 |
| Sep 30, 2021 | 400.94 Mn |
API Access
Pharming Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();